Meritz Securities

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 1, 2020	ILIAS Biologics	$20.6M Series B	—	Asset One, Daedeok Venture Partners, Daishin Private Equity, Dev Sisters Ventures, Genie Asset Management, Hanyang Securities/Yeolim Partners, HB Investment, Kiwoom Securities, Timefolio Asset Management

Total Raised

N/A

Valuation

N/A